vs
Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.
TECHPRECISION CORP is the larger business by last-quarter revenue ($7.1M vs $3.9M, roughly 1.8× Opus Genetics, Inc.). On growth, TECHPRECISION CORP posted the faster year-over-year revenue change (-6.9% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -9.2%).
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.
IRD vs TPCS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $7.1M |
| Net Profit | — | $-1.5M |
| Gross Margin | — | 5.4% |
| Operating Margin | — | -19.1% |
| Net Margin | — | -20.8% |
| Revenue YoY | -10.2% | -6.9% |
| Net Profit YoY | 53.0% | -84.4% |
| EPS (diluted) | — | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $7.1M | ||
| Q3 25 | $3.1M | $9.1M | ||
| Q2 25 | $2.9M | $7.4M | ||
| Q1 25 | $4.4M | $9.5M | ||
| Q4 24 | $4.3M | $7.6M | ||
| Q3 24 | $3.9M | $8.9M | ||
| Q2 24 | $1.1M | $8.0M | ||
| Q1 24 | $1.7M | $8.6M |
| Q4 25 | — | $-1.5M | ||
| Q3 25 | $-17.5M | $825.0K | ||
| Q2 25 | $-7.4M | $-597.0K | ||
| Q1 25 | $-8.2M | $112.0K | ||
| Q4 24 | — | $-799.0K | ||
| Q3 24 | $-7.5M | $-601.0K | ||
| Q2 24 | $-7.8M | $-1.5M | ||
| Q1 24 | $-7.1M | $-5.1M |
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 14.0% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 14.3% |
| Q4 25 | — | -19.1% | ||
| Q3 25 | -269.9% | 10.4% | ||
| Q2 25 | -309.0% | -6.3% | ||
| Q1 25 | -227.2% | 3.9% | ||
| Q4 24 | — | -9.1% | ||
| Q3 24 | -207.1% | -5.5% | ||
| Q2 24 | -748.9% | -16.8% | ||
| Q1 24 | -450.5% | -28.6% |
| Q4 25 | — | -20.8% | ||
| Q3 25 | -566.9% | 9.1% | ||
| Q2 25 | -257.5% | -8.1% | ||
| Q1 25 | -187.5% | 1.2% | ||
| Q4 24 | — | -10.5% | ||
| Q3 24 | -194.6% | -6.7% | ||
| Q2 24 | -698.3% | -18.3% | ||
| Q1 24 | -415.3% | -59.5% |
| Q4 25 | — | $-0.15 | ||
| Q3 25 | $-0.25 | $0.08 | ||
| Q2 25 | $-0.12 | $-0.06 | ||
| Q1 25 | $-0.24 | $0.01 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | $-0.29 | $-0.06 | ||
| Q2 24 | $-0.30 | $-0.16 | ||
| Q1 24 | $-0.29 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $45.1M | $50.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.3M | $8.0M |
| Total Assets | $50.2M | $32.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | $50.0K | ||
| Q3 25 | $30.8M | $220.0K | ||
| Q2 25 | $32.4M | $143.0K | ||
| Q1 25 | $41.8M | $195.0K | ||
| Q4 24 | $30.3M | $165.0K | ||
| Q3 24 | $36.6M | $132.0K | ||
| Q2 24 | $41.4M | $44.8K | ||
| Q1 24 | $47.2M | $138.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | — | $19.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $15.3M | $8.0M | ||
| Q3 25 | $6.0M | $9.1M | ||
| Q2 25 | $17.5M | $8.2M | ||
| Q1 25 | $5.1M | $8.7M | ||
| Q4 24 | $6.7M | $8.1M | ||
| Q3 24 | $34.3M | $8.9M | ||
| Q2 24 | $40.6M | $7.9M | ||
| Q1 24 | $46.1M | $7.8M |
| Q4 25 | $50.2M | $32.8M | ||
| Q3 25 | $36.1M | $33.8M | ||
| Q2 25 | $38.7M | $32.1M | ||
| Q1 25 | $48.2M | $33.5M | ||
| Q4 24 | $36.9M | $32.2M | ||
| Q3 24 | $40.4M | $35.0M | ||
| Q2 24 | $44.8M | $35.7M | ||
| Q1 24 | $51.8M | $34.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-35.3M | $183.0K |
| Free Cash FlowOCF − Capex | — | $-827.0K |
| FCF MarginFCF / Revenue | — | -11.7% |
| Capex IntensityCapex / Revenue | — | 14.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-35.3M | $183.0K | ||
| Q3 25 | $-6.2M | $-1.1M | ||
| Q2 25 | $-10.3M | $646.0K | ||
| Q1 25 | $-9.0M | $396.0K | ||
| Q4 24 | $-25.6M | $-570.0K | ||
| Q3 24 | $-5.1M | $-532.0K | ||
| Q2 24 | $-7.3M | $107.0K | ||
| Q1 24 | $-5.7M | $-452.0K |
| Q4 25 | — | $-827.0K | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | — | $-604.0K | ||
| Q1 25 | — | $-930.0K | ||
| Q4 24 | — | $-1.7M | ||
| Q3 24 | — | $-2.0M | ||
| Q2 24 | — | $-94.0K | ||
| Q1 24 | — | $-900.0K |
| Q4 25 | — | -11.7% | ||
| Q3 25 | — | -22.9% | ||
| Q2 25 | — | -8.2% | ||
| Q1 25 | — | -9.8% | ||
| Q4 24 | — | -22.9% | ||
| Q3 24 | — | -21.8% | ||
| Q2 24 | — | -1.2% | ||
| Q1 24 | — | -10.5% |
| Q4 25 | — | 14.2% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | 16.9% | ||
| Q1 25 | — | 14.0% | ||
| Q4 24 | — | 15.4% | ||
| Q3 24 | — | 15.9% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRD
Segment breakdown not available.
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
